Freeman Kevin Lee bought HCAT
February 20, 2024 · Form 4 insider transaction
Freeman Kevin Lee bought 3,334 shares of Health Catalyst, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,334
Price
$0.00
Total value
N/A
InsiderFreeman Kevin Lee
RoleOfficer
CompanyHealth Catalyst, Inc. (HCAT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2024
Filing dateFebruary 22, 2024
Shares owned after281,144
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of 3,334 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.